RFM News and Press, RiverNorth Flexible Municipal Income Fund Inc.

RFM - Sensorion Announces the Appointment of Laurene Danon as Chief Financial Officer

Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces the appointment of Ms Laurene Danon ...

RFM - (RFM) Trading Advice

2024-06-24 06:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

RFM - Sensorion Announces Upcoming Presentation of Promising SENS-401 Results at the Next International Conference on Cochlear Implants and Other Implantable Technologies

Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces that promising new data and analysis...

RFM - Sensorion Announces its Participation in Upcoming Investor Conferences in June 2024

Regulatory News: Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces its participation ...

RFM - Sensorion Provides Preliminary Documents for the Combined Shareholders' General Meeting of May 29, 2024

Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces that the Company’s shareholde...

RFM - Sensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT) Annual Meeting

Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces its participation in the 27 th A...

RFM - Sensorion Announces its Participation in the Van Lanschot Kempen's Life Sciences Conference

Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces its participation in the Van Lanscho...

RFM - Sensorion Announces a Euro15 Million Financing, Extending Cash Runway Until the End of 2025

Support from existing investors including Redmile Group, Invus, Sofinnova Partners and a large investment management firm Financing will enable the Company to extend its cash runway through the end of 2025 Regulatory News: Sensorion (FR0012596468 – ALSEN) ...

RFM - RiverNorth Flexible Municipal Income Fund declares $0.0954 dividend

2024-04-02 12:25:47 ET More on RiverNorth Flexible Municipal Income Fund Dividend scorecard for RiverNorth Flexible Municipal Income Fund Read the full article on Seeking Alpha For further details see: RiverNorth Flexible Municipal Income Fund declares $0.0954 di...

RFM - Sensorion Announces the Availability of Its Letter to Shareholders

Regulatory News: Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces the publication of...

Company Name:	RiverNorth Flexible Municipal Income Fund Inc.
Stock Symbol:	RFM
Market:	NYSE
Website:	rivernorth.com/closed-end-funds/rmi